文献速递先天性心脏病外科

右室-肺动脉导管Norwood手术:单中心20年经验

Norwood procedure with right ventricle to pulmonary artery conduit: a single-centre 20-year experience.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

该单中心回顾性观察研究纳入1998至2017年接受右室-肺动脉(RV-PA)导管Norwood手术的136例左心发育不良复合体患者,分析生存、再干预与Fontan完成情况。1、5、20年总体生存率分别为80.9%、72.3%、62.8%,68%的患者完成Fontan。

要点

  • RV-PA导管Norwood手术1、5、20年总体生存率分别为80.9%、72.3%、62.8%。
  • 第2、3阶段因肺动脉狭窄再干预的比例分别为22%和30%。
  • Norwood手术时体重<2.5 kg等因素与总体死亡风险相关。

核心结论

  • 在当前以RV-PA导管Norwood手术作为首阶段姑息策略的方案下,生存率与Fontan完成概率可接受。
  • 通过分期修复维持肺动脉生长与心室功能至关重要。

研究设计与样本

  • 单中心回顾性观察研究,纳入1998至2017年136例接受RV-PA导管Norwood手术的左心发育不良复合体患者。
  • 分析生存、再干预与Fontan完成的概率。

主要发现

  • 第1阶段生存率为91.9%(125/136)。
  • 第2、3阶段因肺动脉狭窄需再干预的比例分别为22%和30%,15%因主动脉弓再缩窄接受再干预。
  • 106例双向Glenn术后存活者中93例(占全部患者68%)完成Fontan,4例不考虑为Fontan候选。
  • 总体生存率1年80.9%、5年72.3%、20年62.8%。

关键数值与推荐

  • 总体死亡风险因素包括Norwood手术时体重<2.5 kg、完整房间隔、完全性肺静脉异位连接及Norwood手术时超过轻度的房室瓣反流。

临床怎么用

  • 可将RV-PA导管Norwood手术作为左心发育不良复合体的首阶段姑息策略。
  • 分期修复中应重视维持肺动脉生长与心室功能,并关注房室瓣反流与右心室功能变化。

局限性

  • 为单中心回顾性观察研究,结论的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to evaluate the long-term outcomes of the Norwood procedure with right ventricle-pulmonary artery (RV-PA) conduit for hypoplastic left heart complex. METHODS: A retrospective observational study was performed in 136 patients with hypoplastic left heart complex who underwent a Norwood procedure with RV-PA conduit between 1998 and 2017. The probabilities of survival, reintervention and Fontan completion were analysed. RESULTS: Stage 1 survival was 91.9% (125/136). Reintervention for PA stenosis was needed for 22% and 30% at stages 2 and 3, respectively, while 15% underwent reintervention for aortic arch recoarctation. Among 106 bidirectional Glenn survivors, 93 (68% of the total number of patients) had a Fontan completion, while 4 were not considered to be Fontan candidates. Risk factors for overall mortality included weighing <2.5 kg at the time of the Norwood procedure, intact atrium septum, total anomalous pulmonary vein connection and more than mild atrioventricular regurgitation at the time of the Norwood procedure. Overall survival was 80.9%, 72.3% and 62.8% at 1, 5 and 20 years, respectively. CONCLUSIONS: Probabilities of survival and Fontan completion were acceptable under the current surgical strategy incorporating RV-PA Norwood procedure as the first palliation. Incorporating a strategy to maintain PA growth and ventricular function through the staged repair is of prime importance. Further studies are necessary to observe changes in atrioventricular regurgitation as well as in right ventricular function, in patients who require atrioventricular valve interventions during the staged Fontan completion.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kobayashi Y, Kotani Y, Kuroko Y, et al. Norwood procedure with right ventricle to pulmonary artery conduit: a single-centre 20-year experience. Eur J Cardiothorac Surg. 2020. PMID: 32211760. doi:10.1093/ejcts/ezaa041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。